Centessa Pharmaceuticals plc (CNTA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 10.78 |
| Open | 10.68 |
| Bid | 10.53 x 100 |
| Ask | 10.57 x 100 |
| Day's range | 10.37 - 10.84 |
| 52-week range | 3.96 - 12.45 |
| Volume | |
| Avg. volume | 399,851 |
| Market cap | 1.056B |
| Beta (5Y monthly) | 1.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.57 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 13.60 |
- GuruFocus.com
Centessa Pharmaceuticals PLC (CNTA) Earnings: A Detailed Look at Q4 and Full-Year 2023 Results
Aligning with EPS Projections, CNTA Reports a Net Loss Decrease in Q4
GlobeNewswireCentessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
Hemophilia Program: Ongoing registrational PRESent-2 and PRESent-3 studies of SerpinPC for the treatment of hemophilia B; PRESent-2 advancing toward interim analysis planned in 2024Orexin Agonist Program: Clinical proof-of-concept data for ORX750 in sleep-deprived healthy volunteers planned in 2024LockBody® Technology Platform: Ongoing Phase 1/2a study of LB101 (PD-L1xCD47) for the treatment of solid tumors BOSTON and LONDON, March 28, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasda
GuruFocus.comCentessa Pharmaceuticals PLC Chief People Officer Sells Company Shares
Karen Anderson, the Chief People Officer of Centessa Pharmaceuticals PLC (NASDAQ:CNTA), has sold 51,160 shares of the company on March 25, 2024, according to a recent SEC Filing.
© 2024 Yahoo. All rights reserved.